Expanded Access for Repotrectinib

Sponsor
Bristol-Myers Squibb
Study ID
NCT05926232
Status
Available

Eligibility Criteria

Sex
All
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

This is an expanded access designed to provide access to Repotrectinib for eligible participants.

Key Dates

First listed
Jul 3, 2023
Status verified
Jun 2023

Central Contacts

  • BMS Study Connect Contact Center http://www.bmsstudyconnect.com
    855-907-3286
    [email protected]
  • First line of the email MUST contain NCT # and Site #.